Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03157037 |
|---|---|
| Brief Title: | Open-Label Phase II Study to Evaluate the Efficacy and Safety of IdeS in Anti-GBM Disease (GOOD-IDES-01) |
| First Submitted : | May 11, 2017 |
| First Submitted that Met QC Criteria : | May 15, 2017 |
| First Posted : | May 17, 2017 |
| Results First Submitted : | December 20, 2021 |
| Results First Submitted that Met QC Criteria : | February 7, 2022 |
| Results First Posted : | April 7, 2022 |
| Last Update Submitted that Met QC Criteria : | February 7, 2022 |
| Last Update Posted : | April 7, 2022 |